Autologous Conditioned Serum in the Treatment of Patients with Orthopedic Diseases: Literature Review

Radygina L. V.
Researcher, Department of Scientific Information «Life Sciences»¹

1 - All-Russian Institute for Scientific and Technical Information of the Russian Academy of Sciences (VINITI RAS), Moscow, Russian Federation

Radygina Lubov; e-mail: lubardygina@yandex.ru

None declared.

The study had no sponsorship.

Treatment of orthopedic diseases is a pressing problem. Autologous conditioned serum is used in the treatment of osteoarthritis and exhibits a pronounced analgesic effect and improves joint function without significant side effects, even in cases resistant to other treatments. Autologous conditioned serum is also successfully used for meniscus pathology, tendon diseases, and osteochondrosis. Treatment with autologous conditioned serum is not only an effective method, but is also economically affordable.

orthopedic diseases, autologous conditioned serum, treatment

10.29234/2308-9113-2024-12-1-109-117

1. Lebedeva Ye.A. Kliniko-epidemiologicheskaya kharakteristika zabolevaniy sustavov u gorodskogo naseleniya [Clinical and epidemiological characteristics of joint diseases in the urban population] Avtoref. diss. na soiskaniye uchenoy stepeni k.m.n. [Author's abstract, PhD Thesis] Moscow, 2007. 22 p. (In Russ.)

2. Wehling P., Moser C., Frisbie D., McIlwraith C.W., Kawcak C.E., Krauspe R., Reinecke J.A. Autologous conditioned serum in the treatment of orthopedic diseases: the orthokine therapy. BioDrugs 2007; 21(5): 323-332, doi: 10.2165/00063030-200721050-00004

3. Evans C.H., Chevalier X., Wehling P. Autologous Conditioned Serum. Phys Med Rehabil Clin N Am. 2016; 27(4): 893-908, doi: 10.1016/j.pmr.2016.06.003

4. Shakouri S.K., Dolati S., Santhakumar J., Thakor A.S., Yarani R. Autologous conditioned serum for degenerative diseases and prospects. Growth Factors 2021; 39(1-6): 59-70, doi: 10.1080/08977194.2021.2012467

5. Meijer H., Reinecke J., Becker C., Tholen G., Wehling P. The production of anti-inflammatory cytokines in whole blood by physico-chemical induction. Inflamm Res. 2003; 52(10): 404-407, doi: 10.1007/s00011-003-1197-1

6. Lebedev N.N., Shikhmetov A.N., Zhdanovich V.V., Min'ko A.I., Khalatov V.S. Ortokin-terapiya v usloviyakh mnogoprofil'noy polikliniki [Orthokine therapy in a multidisciplinary clinic]. Vestnik Natsional'nogo mediko-khirurgicheskogo Tsentra im. N. I. Pirogova [Bulletin of N.I. Pirogov National Medical and Surgical Center] 2014; 9(1):72-75. (In Russ.).

7. Blázquez R., Sánchez-Margallo F.M., Reinecke J., Álvarez V., López E., Marinaro F., Casado J.G. Conditioned Serum Enhances the Chondrogenic and Immunomodulatory Behavior of Mesenchymal Stem Cells. Front Pharmacol. 2019; 10: 699, doi: 10.3389/fphar.2019.00699

8. Pishgahi A., Zamani M., Mehdizadeh A., Roshangar L., Afkham-Daghdaghan M., Pourabbas B., Yousefi M. The therapeutic effects of autologous conditioned serum on knee osteoarthritis: an animal model. BMC Res Notes 2022; 15(1): 277, doi: 10.1186/s13104-022-06166-1

9. Raeissadat S.A., Rayegani S.M., Sohrabi M.R., Jafarian N., Bahrami M.N. Effectiveness of intra-articular autologous-conditioned serum injection in knee osteoarthritis: a meta-analysis study. Future Sci OA 2021; 7(9): FSO759, doi: 10.2144/fsoa-2021-0069

10. Angadi D.S., Macdonald H., Atwal N. Autologous cell-free serum preparations in the management of knee osteoarthritis: what is the current clinical evidence? Knee Surg Relat Res. 2020; 32(1): 16, doi: 10.1186/s43019-020-00036-5

11. Vitali M., Ometti M., Drossinos A., Pironti P., Santoleri L., Salini V. Autologous conditioned serum: clinical and functional results using a novel disease modifying agent for the management of knee osteoarthritis. J Drug Assess. 2020; 9(1): 43-51, doi: 10.1080/21556660.2020.1734009

12. Barreto A., Braun T.R. A new treatment for knee osteoarthritis: Clinical evidence for the efficacy of Arthrokinex™ autologous conditioned serum. J Orthop. 2016; 14(1): 4-9, doi: 10.1016/j.jor.2016.10.008

13. Ippolito M., Spurio G., Compagno V., Rizzo A., Di Simone M., Corsale A.M., Mazzola G., Giarratano A., Meraviglia S., Cortegiani A., Alongi A. Autologous conditioned serum for chronic pain in patients with osteoarthritis: A feasibility observational study. Br J Pain 2023; 17(1): 103-111, doi: 10.1177/20494637221134169

14. Coşkun H.S., Yurtbay A., Say F. Platelet Rich Plasma Versus Autologous Conditioned Serum in Osteoarthritis of the Knee: Clinical Results of a Five-Year Retrospective Study. Cureus 2022; 14(4): e24500, doi: 10.7759/cureus.24500

15. Leone R., de Rosa A., Iudicone P., Fioravanti D., Capua G., Rossetti F., Isgro' M.A., Pierelli L. Pain control and functional improvement in patients treated by autologous conditioned serum after failure of platelet rich plasma treatments in knee osteoarthritis. Transfus Med. 2021; 31(5): 357-364, doi: 10.1111/tme.12801

16. Cheng P.G., Yang K.D., Huang L.G., Wang C.H., Ko W.S. Comparisons of Cytokines, Growth Factors and Clinical Efficacy between Platelet-Rich Plasma and Autologous Conditioned Serum for Knee Osteoarthritis Management. Biomolecules 2023; 13(3): 555, doi: 10.3390/biom13030555

17. Khurana A., Goyal A., Kirubakaran P., Akhand G., Gupta R., Goel N. Efficacy of Autologous Conditioned Serum (ACS), Platelet-Rich Plasma (PRP), Hyaluronic Acid (HA) and Steroid for Early Osteoarthritis Knee: A Comparative Analysis. Indian J Orthop. 2020; 55(Suppl 1): 217-227, doi: 10.1007/s43465-020-00274-5

18. Damjanov N., Zekovic A. Intra-articular autologous conditioned serum and triamcinolone injections in patients with knee osteoarthritis: a controlled, randomized, double-blind study. J Int Med Res. 2023; 51(10): 3000605231203851, doi: 10.1177/03000605231203851

19. Pishgahi A., Abolhasan R., Shakouri S.K., Soltani-Zangbar M.S., Dareshiri S., Ranjbar Kiyakalayeh S., Khoeilar A., Zamani M., Motavalli Khiavi F., Pourabbas Kheiraddin B., Mehdizadeh A., Yousefi M. Effect of Dextrose Prolotherapy, Platelet Rich Plasma and Autologous Conditioned Serum on Knee Osteoarthritis: A Randomized Clinical Trial. Iran J Allergy Asthma Immunol. 2020; 19(3): 243-252, doi: 10.18502/ijaai.v19i3.3452

20. García-Escudero J.B., Trillos P.M.H. Treatment of Osteoarthritis of the Knee with a Combination of Autologous Conditioned Serum and Physiotherapy: A Two-Year Observational Study. PLoS One 2015; 10(12): e0145551, doi: 10.1371/journal.pone.0145551

21. Strümper R. Intra-Articular Injections of Autologous Conditioned Serum to Treat Pain from Meniscal Lesions. Sports Med Int Open 2017; 1(6): E200-E205, doi: 10.1055/s-0043-118625.

22. Simon M.J.K., Aartsen V.E., Coghlan J.A., Strahl A., Bell S.N. Shoulder injections with autologous conditioned serum reduce pain and disability in glenohumeral osteoarthritis: longitudinal observational study. ANZ J Surg. 2021; 91(4): 673-679, doi: 10.1111/ans.16672

23. Ipek D., Çalbıyık M., Zehir S. Intratendinous Injection of Autologous Conditioned Serum for Treatment of Lateral Epicondylitis of the Elbow: A Pilot Study. Arch Iran Med. 2022; 25(5): 319-323, doi: 10.34172/aim.2022.52

24. Damjanov N., Barac B., Colic J., Stevanovic V., Zekovic A., Tulic G. The efficacy and safety of autologous conditioned serum (ACS) injections compared with betamethasone and placebo injections in the treatment of chronic shoulder joint pain due to supraspinatus tendinopathy: a prospective, randomized, double-blind, controlled study. Med Ultrason. 2018; 20(3): 335-341, doi: 10.11152/mu-1495

25. Godek P., Szczepanowska-Wolowiec B., Golicki D. Comparison of Analgesic Efficacy between Epidural and Perineural Administration of Autologous Conditioned Serum in the Conservative Treatment of Low Back Pain Due to Lumbar Degenerative Disc Disease: A Randomized, Open-Label, Controlled Clinical Trial. Brain Sci. 2023; 13(5): 749, doi: 10.3390/brainsci13050749

26. Raeissadat S.A., Rayegani S.M., Jafarian N., Heidari M. Autologous conditioned serum applications in the treatment of musculoskeletal diseases: a narrative review. Future Sci OA 2022; 8(2): FSO776, doi: 10.2144/fsoa-2021-0088